Neena M. Patil - 01 Jun 2023 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role: EVP & Chief Legal Officer
Signature: By: /s/Adam Guttmann, as attorney in fact For: Neena M Patil
Issuer symbol: JAZZ
Transactions as of: 01 Jun 2023
Net transactions value: -$204,763
Form type: 4
Filing time: 05 Jun 2023, 20:24:09 UTC
Previous filing: 11 May 2023
Next filing: 09 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JAZZ	Ordinary Shares	Sale	$195,290	-1,526	-4.4%	$127.98	32,900	01 Jun 2023	Direct	F1, F2
transaction	JAZZ	Ordinary Shares	Sale	$9,473	-74	-0.22%	$128.02	32,826	01 Jun 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $127.91 to $128.015. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F2	Includes 87 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2023.

Content

Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $127.91 to $128.015. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Includes 87 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2023.